New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
13:25 EDTILMN, ILMN, ILMN, LMNX, LMNX, LMNX, CPHD, CPHD, CPHD, GNMK, GNMK, GNMK, NSTG, NSTG, NSTG, MYGN, MYGN, MYGN, FLDM, FLDM, FLDM, PACB, PACB, PACB, TMO, TMO, TMO, QGEN, QGEN, QGENLeerink's life science tools analyst holds an analyst/industry conference call
Life Science Tools Analyst Leonard discusses the use of nextgen sequencing in a clinical context, early applications and uptake, the merits, demerits of various nextgen sequencing instruments and where new offerings fit on an Analyst/Industry conference call. Relevant companies ILMN, TMO, PACB, FLDM, MYGN, NSTG, GNMK, CPHD, LMNX and QGEN may be discussed on the Analyst/Industry conference call to be held on April 3 at 2 pm.
News For ILMN;TMO;PACB;FLDM;MYGN;NSTG;GNMK;CPHD;LMNX;QGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 16, 2014
16:09 EDTCPHDCepheid reports Q3 EPS ex-items 6c, consensus (16c)
Subscribe for More Information
10:01 EDTILMNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:33 EDTILMNIllumina upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
October 15, 2014
08:52 EDTLMNXLuminex CEO PAtrick Baithrop retiring, succeeded by Nachum Shamir
Luminex President and CEO Patrick J. Balthrop, Sr. has retired. The board of directors has named Nachum "Homi" Shamir as President and CEO. Mr. Balthrop will continue to serve the company and its shareholders as a consultant to the Board and Mr. Shamir, and will be assisting in the transition through April 14, 2015.
07:43 EDTPACBPacific Biosciences releases new enhancing DNA sequencing chemistry
Subscribe for More Information
06:32 EDTILMNIllumina to invest in three genomics industry startups
Illumina selected three startup companies for the inaugural Illumina Accelerator funding cycle. The companies are Encoded Genomics, EpiBiome and Xcell Biosciences. The Illumina Accelerator will provide selected startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during the six-month cycle.
October 14, 2014
14:21 EDTTMOThermo Fisher confirms review of alleged Kinetica bugs, Reuters reports
Subscribe for More Information
08:15 EDTILMNIllumina should report stronger than expected results, says Wedbush
Subscribe for More Information
07:48 EDTCPHDCepheid recent weakness unjustified, says Canaccord
Subscribe for More Information
October 9, 2014
14:54 EDTMYGNCapital World Investors reports 10.5% passive stake in Myriad Genetics
10:00 EDTQGEN, LMNXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTLMNXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Acuity Brands (AYI) upgraded at Oppenheimer... Agnico-Eagle (AEM) upgraded to Buy from Hold at Desjardins... Apple (AAPL) upgraded to Outperform from Perform at Oppenheimer... Bank of Montreal (BMO) upgraded to Buy from Hold at Canaccord... Basic Energy (BAS) upgraded to Hold from Underperform at Jefferies... BreitBurn Energy (BBEP) upgraded to Outperform from Perform at Oppenheimer... Golden Minerals (AUMN) upgraded at Roth Capital... Helmerich & Payne (HP) upgraded to Buy from Hold at Jefferies... II-VI (IIVI) upgraded to Buy from Neutral at DA Davidson... LivePerson (LPSN) upgraded at Credit Suisse... Luminex (LMNX) upgraded to Market Perform at Cowen... MGM Resorts (MGM) upgraded at Craig-Hallum... New Gold (NGD) upgraded to Buy from Hold at Desjardins... New Source Energy (NSLP) upgraded to Outperform from Perform at Oppenheimer... Pacific Coast Oil (ROYT) upgraded to Buy from Hold at Stifel... Pioneer Energy (PES) upgraded to Buy from Hold at Jefferies... Precision Drilling (PDS) upgraded to Strong Buy from Outperform at Raymond James... Randgold (GOLD) upgraded to Overweight from Neutral at HSBC... Resource Capital (RSO) upgraded to Buy from Hold at MLV & Co.... Toyota (TM) upgraded to Buy from Neutral at BofA/Merrill... Transocean (RIG) upgraded to Outperform from Sector Perform at Iberia... Universal Technical (UTI) upgraded to Outperform from Market Perform at Wells Fargo... Vulcan Materials (VMC) upgraded to Buy from Neutral at Longbow.
08:16 EDTCPHDCepheid price target lowered to $54 from $58 at Cowen
Cowen lowered its price target on Cepheid to $54 from $58 ahead of the company's Q3 results. The firm sees a modest upside to estimates and believes the company is well positioned for an acceleration of Commercial growth in 2015. Near term, however, Cowen sees only modest upside, but little risk, and maintains its Outperform rating on Cepheid shares.
08:15 EDTLMNXLuminex upgraded to Market Perform at Cowen
Subscribe for More Information
07:46 EDTQGENQIAGEN initiated with a Neutral at Citigroup
Target $25.
07:46 EDTCPHDCepheid initiated with a Buy at Citigroup
Subscribe for More Information
07:46 EDTLMNXLuminex initiated with a Neutral at Citigroup
Target $21.
06:45 EDTLMNXLuminex upgraded to Market Perform from Underperform at Cowen
Subscribe for More Information
October 8, 2014
16:09 EDTMYGNMyriad Genetics appoints former LabCorp executive Riggsbee as CFO
Myriad Genetics (MYGN) announced the appointment of R. Bryan Riggsbee as executive vice president, CFO, and Treasurer effective October 16. Jim Evans will continue in his role as CFO through the transition to Riggsbee, the company stated. Riggsbee most recently served as the senior vice president, Corporate Finance at Laboratory Corporation of America (LH).
07:18 EDTQGEN, CPHDInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use